Danaher is considered one of the leading companies in the global diagnostic market along with Roche and Abbott. Danaher's growth engine, born in 1984, lies in aggressive M&A. So far, it has grown in size with more than 50 M&As. Rather than developing its own technology when entering a new market, it mainly used the method of acquiring promising companies and settling in the market with active management participation. It has grown into a comprehensive medical device company by acquiring companies in various fields such as molecular diagnostic company Cepheid, tooth implant manufacturing company Nobel Biocare, and diagnostic reagent company Beckman Coulter.

Danaher didn't just focus on increasing the siz